会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明公开
    • 싸이클로덱스트린에 결합하는 펩티드, 그의 제조방법 및 용도
    • CYCLODEXTRIN-BINIDNG PEPTIDES,其制备方法及其使用
    • KR1020130018212A
    • 2013-02-20
    • KR1020120153771
    • 2012-12-26
    • 강릉원주대학교산학협력단
    • 최석정최병학
    • C07K7/06C08B37/16C07K17/10C40B40/10
    • C07K7/06C07K7/00C07K17/10
    • PURPOSE: A peptide which binds to cyclodextrin and a method for preparing the same are provided to ensure easy fixation on a cyclodextrin polymer. CONSTITUTION: A peptide library for conjugating cyclodextrin contains LPVRPWT(CD-01), LPLTPLP(CD-02), LPPQTLI(CD-03), or NQDVPLF(CD-04) sequence as an active ingredient. A functional group or a ligand to cyclodextrin is introduced using the peptide library. A cyclodextrin-conjugated peptide complex is a fusion protein with a certain protein, and prepared by conjugating the certain protein with the cyclodextrin. [Reference numerals] (1) Combining by adding a library to CD polymer beads; (2) Settling the beads by centrifugation; (3) Removing uncombined phage; (4) Culturing the combined phage and repeating (1) to (3) steps 5 times; (5) Analyzing the base sequences of 10 finally collected phages; (6) Determining amino acid sequence; (AA) CD polymer beads
    • 目的:提供与环糊精结合的肽及其制备方法,以确保在环糊精聚合物上容易固定。 构成:用于缀合环糊精的肽文库含有LPVRPWT(CD-01),LPLTPLP(CD-02),LPPQTLI(CD-03)或NQDVPLF(CD-04)序列作为活性成分。 使用肽文库引入功能基团或环糊精的配体。 环糊精缀合的肽复合物是具有某种蛋白质的融合蛋白,通过将某些蛋白质与环糊精缀合而制备。 [参考数字](1)通过向CD聚合物珠添加文库来组合; (2)离心沉淀珠粒; (3)去除未结合的噬菌体; (4)培养联合噬菌体并重复(1)至(3)步骤5次; (5)分析10个最终收集的噬菌体的碱基序列; (6)确定氨基酸序列; (AA)CD聚合物珠
    • 6. 发明公开
    • 생리활성 폴리펩타이드 결합체 제조 방법
    • 生物活性多肽共聚物的制备方法
    • KR1020130049671A
    • 2013-05-14
    • KR1020110114828
    • 2011-11-04
    • 한미사이언스 주식회사
    • 김대진장명현김승수이종수최재혁권세창
    • C07K17/10C07K17/08C07K1/18
    • C07K14/62A61K47/60C07K1/1077C07K17/08C07K2319/30C07K2319/31C07K17/10C07K1/18
    • PURPOSE: A method for preparing a physiologically active polypeptide conjugate is provided to highly maintain activity in vivo, to remarkably increase a half life in blood, and to enhance drug compliance. CONSTITUTION: A method for preparing a physiologically active polypeptide and non-polypeptide polymer connector comprises: a step of reacting a physiologically active polypeptide and a non-polypeptide polymer in a reaction solution containing an organic solvent; and a step of isolating and purifying the physiologically active polypeptide connector from the reacted mixture. The organic solvent is C1-C10 alcohol. The alcohol is selected from the group consisting of isopropanol, ethanol, and methanol. The reaction solution contains 10-60wt% of organic solvent. [Reference numerals] (AA) Insulin beta chain; (BB) Insulin alpha chain; (CC) PEG_insulin beta chain
    • 目的:提供一种制备生理活性多肽缀合物的方法,以高度保持体内的活性,显着增加血液中的半衰期,并提高药物依从性。 构成:制备生理活性多肽和非多肽聚合物连接体的方法包括:使生理活性多肽和非多肽聚合物在含有机溶剂的反应溶液中反应的步骤; 以及从反应混合物中分离和纯化生理活性多肽连接体的步骤。 有机溶剂为C1-C10醇。 醇选自异丙醇,乙醇和甲醇。 反应溶液含有10-60重量%的有机溶剂。 (AA)胰岛素β链; (BB)胰岛素α链; (CC)PEG胰岛素β链
    • 8. 发明公开
    • 하이드록시알킬 전분 유도체의 제조 방법
    • 生产羟基烷基淀粉衍生物的方法
    • KR1020050061466A
    • 2005-06-22
    • KR1020057003902
    • 2003-08-08
    • 프레제니우스 카비 도이치란트 게엠베하
    • 잰테르,노르베르트콘라드트헤럴드에이크너울프람
    • C08B31/12C08B31/00C08B31/10
    • C08B31/12A61K9/0021A61K38/00A61K47/61C07K14/505C07K14/53C07K14/5412C07K14/55C07K14/56C07K14/565C07K17/10C08B31/00C08B31/006C08B31/08C08B31/185C08H1/00
    • The present invention relates to a method of producing a hydroxyalkyl starch derivative, said hydroxyalkyl starch having a structure according to formula (I) comprising reacting - hydroxyalkyl starch o formula (I) at its optionally oxidized reducing end or - a hydroxyalkyl starch derivative, obtainable by reacting hydroxyalkyl starch of formula (I) at its optionally oxidized reducing end with a compound (D), said compound (D) comprising - at least one functional group Z1 capable of being reacted with the optionally oxidized reducing end of the hydroxyalkyl starch, and at least one functional group W, with a compound (L) comprising at least one functional group Z1 capable of being reacted with said hydroxyalkyl starch, or at least one functional group Z2 capable of being reacted with functional group W comprised in said hydroxyalkyl starch derivative, and at least one functional group X capable of being reacted with a functional group Y of a further compound (M), wherein said functional group Y is selected from the group consisting of an aldehyd group, a keto group, a hemiacetal group, an acetal group, and a thio group. The present invention further relates to the hydroxyalkyl starch derivatives as such ans a pharmaceutical composition comprising the hydroxyalkyl starch derivatives.
    • 本发明涉及一种生产羟烷基淀粉衍生物的方法,所述羟烷基淀粉具有根据式(I)的结构,包括在其任意氧化的还原性末端反应式(I)羟烷基淀粉或可得到的羟烷基淀粉衍生物 通过使式(I)的羟烷基淀粉在其任选被氧化的还原端与化合物(D)反应,所述化合物(D)包含至少一个能够与任选氧化的羟烷基淀粉的还原端反应的官能团Z1, 和至少一个官能团W,其中化合物(L)包含至少一个能够与所述羟烷基淀粉反应的官能团Z1,或至少一个能够与所述羟烷基淀粉中包含的官能团W反应的官能团Z2 衍生物和至少一种能够与其它化合物(M)的官能团Y反应的官能团X,其中所述官能团 Y组选自醛基,酮基,半缩醛基,缩醛基和硫基。 本发明还涉及这样的羟烷基淀粉衍生物和包含羟烷基淀粉衍生物的药物组合物。
    • 9. 发明公开
    • 생리활성 폴리펩타이드 결합체 제조 방법
    • 生产生理活性多肽结合物的方法
    • KR1020180019634A
    • 2018-02-26
    • KR1020180018494
    • 2018-02-14
    • 한미사이언스 주식회사
    • 김대진장명현김승수이종수최재혁권세창
    • C07K17/10C07K17/08C07K1/18
    • C07K17/10C07K1/18C07K17/08
    • 본발명은생리활성폴리펩타이드의생체내 지속성및 안정성이향상되도록하기위하여, 유기용매를이용하여생리활성폴리펩타이드및 비펩타이드성중합체가공유결합에의해연결된생리활성폴리펩타이드및 비펩타이드성중합체연결체, 및상기연결체에캐리어가결합된생리활성폴리펩타이드결합체를제조하는방법에관한것이다. 본발명의제조방법을통해높은순도와수율로생리활성폴리펩타이드및 비펩타이드성중합체연결체를제조할수 있으며, 이를이용하여제조한생리활성폴리펩타이드결합체는제조비용이절감되며, 생체내 활성이비교적높게유지되고, 혈중반감기가현저히증가되어, 환자의복약순응도를높일수 있는생리활성폴리펩타이드의지속형제형개발에유용하게이용될수 있다.
    • 本发明是生理活性聚为了在体内持久性和多肽的稳定性,以允许改善,使用有机溶剂是生理活性多肽和非肽聚合物是生理活性多肽和非肽聚合物连接通过共价键体附 以及生产具有与连接体结合的载体的生理活性多肽缀合物的方法。 高纯度和能产生高收率的生理活性多肽和非肽聚合物连接器本体,使用这种通过本发明的制造方法应降低生产成本制备生理活性多肽偶联物,体内活性相对 保持高时,显著增加血清半衰期,它可以有效地用于继续其nopilsu患者的服药依从性的生理活性多肽的兄弟姐妹式的发展。